Prostaglandins and CGRP release from cardiac sensory nerves

Naunyn Schmiedebergs Arch Pharmacol. 1989 Aug;340(2):180-4. doi: 10.1007/BF00168966.

Abstract

(1) The possible influence of prostaglandins (PG) E1 and I2 as well as ischaemia, ouabain and bradykinin on the outflow of calcitonin gene-related peptide (CGRP)- and neuropeptide Y (NPY)-like immunoreactivity (LI) from the guinea-pig heart was studied in vitro. (2) Exposure to PGE1 (10(-5) M), but not PGI2 (10(-5) M), induced an increased outflow, suggesting release of CGRP-LI. PGE1 simultaneously increased the contractile force and heart rate while no effects were observed on perfusate volume or outflow of NPY-LI. PGI2 had no effect on contractile parameters or coronary flow. In separate experiments on capsaicin-pretreated animals, the stimulatory effects of PGE1 on heart rate and contractile force remained unchanged while no increased CGRP-LI outflow was detectable. (3) Ouabain, bradykinin and reperfusion after total stop-flow ischaemia was associated with an indomethacin-resistant increase in perfusate levels of CGRP-LI but not of NPY-LI. While ouabain markedly increased the contractile force, exposure to bradykinin or ischaemia did not induce any clear-cut changes in contractile force or heart rate. (4) Capsaicin-exposure evoked a markedly increased outflow of CGRP-LI but not of NPY-LI in combination with an increase in heart rate and a decrease in contractile force. Repeated administration of capsaicin induced tachyphylaxis. The stimulatory effects of capsaicin on CGRP-LI outflow and heart rate, but not the negative inotropic effect, did not occur in capsaicin-pretreated animals. (5) It is concluded that PGE1, but not PGI2, can activate cardiac capsaicin-sensitive fibres as revealed by increased outflow of CGRP-LI.(ABSTRACT TRUNCATED AT 250 WORDS)

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alprostadil / pharmacology
  • Animals
  • Bradykinin / pharmacology
  • Calcitonin Gene-Related Peptide / metabolism*
  • Capsaicin / pharmacology
  • Coronary Disease / physiopathology
  • Epoprostenol / pharmacology
  • Guinea Pigs
  • Heart / drug effects
  • Heart / innervation*
  • In Vitro Techniques
  • Indomethacin / pharmacology
  • Myocardium / metabolism
  • Neurons, Afferent / drug effects
  • Neurons, Afferent / metabolism*
  • Neuropeptide Y / pharmacology
  • Ouabain / pharmacology
  • Prostaglandins / metabolism*
  • Sympathetic Nervous System / drug effects
  • Sympathetic Nervous System / metabolism

Substances

  • Neuropeptide Y
  • Prostaglandins
  • Ouabain
  • Epoprostenol
  • Alprostadil
  • Calcitonin Gene-Related Peptide
  • Capsaicin
  • Bradykinin
  • Indomethacin